USPTO 2015–2025 USPTO PatentsView Foreign Corporation

Qiagen Healthcare Biotechnologies Systems Gmbh

USPTO PatentsView assignee record - 6 granted patents across 10 technology areas, active 2019–2024. Filing-trend and competitive-moat analysis cross-referenced to USPTO Patent Public Search. Primary class: G01N (INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES).

Compiled byPlainPatent Editorial, US Patent Intelligence Editorial Team · May 15, 2026

Explore the portfolio See the ranking

Total patents granted

CPC technology areas

14.2

Avg claims per patent

+400%

5-year filing velocity

The verdict

Qiagen holds 6 US patents across 10 technology areas, rank #42,488 of 50,000 tracked assignees.

#42,488
of 50,000 US assignees by volume: Top 37%
by Innovation Score (39.7/100): 14.2
avg claims per patent: +400%
filing velocity, last 5 yrs

Portfolio overview

Qiagen Healthcare Biotechnologies Systems Gmbh has been granted 6 US utility patents between 2019 and 2024, placing Qiagen Healthcare Biotechnologies Systems Gmbh at rank #42,488 across all assignees tracked by PlainPatent. This portfolio spans 10 distinct Cooperative Patent Classification (CPC) subclasses, averaging 14.2 claims per patent with primary concentration in G01N (INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES). As a Foreign Corporation, Qiagen Healthcare Biotechnologies Systems Gmbh is one of the more focused assignees in the PatentsView dataset. By volume, Qiagen sits between Qatar University Qstp-b (6 patents, rank #42,484) and Qiduo E-commerce (zhejiang) Co., Ltd. (6 patents, rank #42,492) - the closest US assignees by grant volume. The composite Innovation Score of 39.7/100 blends portfolio volume, filing velocity, technology breadth, and claim depth into a single comparable measure drawn directly from USPTO PatentsView records.

Filing cadence tells the strategic story. Between 2020 and 2025 the company received 5 grants, compared with 1 in the 2015–2019 window, a +400% shift in five-year velocity. An acceleration of this magnitude signals aggressive R&D investment and expanding technical ambition. The Foreign Corporation classification further shapes interpretation, since corporate, government, and individual filers pursue patents for materially different reasons.

Claim depth and technology breadth together indicate competitive posture. Qiagen Healthcare Biotechnologies Systems Gmbh's 14.2 average claims per patent sits within the typical range for solid legal coverage without excessive prosecution cost, while concentration in 10 subclasses points to a focused technical program. Combined with portfolio volume, these signals let analysts, investors, and licensing professionals benchmark Qiagen Healthcare Biotechnologies Systems Gmbh against peers pursuing similar technology classes.

Qatar University…

6
Qbiotics PTY

6
QED Labs

6
QGP

6
Qiagen Manchester

6
Qiagen Redwood Ci…

6
Qianjiang Yongan…

6
Qiduo E-commerce…

6
Qiagen Healthcare… ◀

6

What this shows Qiagen holds 6 patents at rank #42,488, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.

Companies ranked near Qiagen

By rank, the assignees closest to #42,488 in granted patent volume.

Leaders in G01N (Investigating OR Analysing Materials BY Determining Their…)

Other assignees with the most granted patents in Qiagen's primary technology class.

Qiagen's Innovation Score vs. every tracked assignee

Composite of portfolio volume, filing velocity, technology breadth, and claim depth (0–100)

40 Top 37% higher than 63% of 50,000 US assignees

Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.

Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025

USPTO utility patent grants by year · 2019–2024

Grants by year

Teal-shaded recent years (2020–present) versus the 2019–2019 baseline. Full figures in the table below.

View data table

Qiagen Healthcare Biotechnologies Systems Gmbh patent grants by year, 2015–2025
Year	Patents Granted	Share of Period
2019	1	16.7%
2021	1	16.7%
2024	4	66.7%

Which technologies does Qiagen Healthcare Biotechnologies Systems Gmbh patent most?

G01N - INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES 4

B01L - CHEMICAL OR PHYSICAL LABORATORY APPARATUS FOR GENERAL USE 3

B65D - CONTAINERS FOR STORAGE OR TRANSPORT OF ARTICLES OR MATERIALS, e.g. BAGS, BARRELS, BOTTLES, BOXES, CANS, CARTONS, CRATES, DRUMS, JARS, TANKS, HOPPERS, FORWARDING CONTAINERS; ACCESSORIES, CLOSURES, OR FITTINGS THEREFOR; PACKAGING ELEMENTS; PACKAGES 2

C12N - MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA 1

C12Q - MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS ; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES 1

A61B - DIAGNOSIS; SURGERY; IDENTIFICATION 1

B26F - PERFORATING; PUNCHING; CUTTING-OUT; STAMPING-OUT; SEVERING BY MEANS OTHER THAN CUTTING 1

B26D - CUTTING; DETAILS COMMON TO MACHINES FOR PERFORATING, PUNCHING, CUTTING-OUT, STAMPING-OUT OR SEVERING 1

B21D - WORKING OR PROCESSING OF SHEET METAL OR METAL TUBES, RODS OR PROFILES WITHOUT ESSENTIALLY REMOVING MATERIAL; PUNCHING METAL 1

Y10T - TECHNICAL SUBJECTS COVERED BY FORMER US CLASSIFICATION 1

Top 10 of 10 technology areas

Patent Moat Analysis

Portfolio Volume Light

Tech Breadth Focused

Claim Depth Standard

Velocity Accelerating

Where it ranks

Overall rank by patents

#42,488

Across all tracked assignees

Innovation Score

39.7 out of 100

View all rankings →

Data Source

USPTO PatentsView, US granted patents 2015–2025

How is Innovation Score calculated?

Frequently Asked Questions

How many patents does Qiagen Healthcare Biotechnologies Systems Gmbh hold?

Qiagen Healthcare Biotechnologies Systems Gmbh holds 6 US granted patents filed between 2019 and 2024, spanning 10 technology areas.

What is Qiagen Healthcare Biotechnologies Systems Gmbh's Innovation Score?

Qiagen Healthcare Biotechnologies Systems Gmbh has an Innovation Score of 39.7 out of 100. This composite metric weighs portfolio volume (40%), filing velocity (20%), technology breadth (25%), and claim depth (15%).

What technology areas does Qiagen Healthcare Biotechnologies Systems Gmbh focus on?

Qiagen Healthcare Biotechnologies Systems Gmbh's top technology area is G01N (INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES) with 4 patents. The company has filed patents in 10 CPC subclasses total.

Is Qiagen Healthcare Biotechnologies Systems Gmbh's patent filing rate increasing or decreasing?

Qiagen Healthcare Biotechnologies Systems Gmbh's recent filing velocity is +400% compared to the prior five-year period. This indicates accelerating innovation.

What does claim depth mean for Qiagen Healthcare Biotechnologies Systems Gmbh's patents?

Qiagen Healthcare Biotechnologies Systems Gmbh's patents average 14.2 claims each. This falls within the standard range, providing solid legal coverage.

How is the Qiagen Healthcare Biotechnologies Systems Gmbh patent data sourced?

All patent data comes from USPTO PatentsView, a public research dataset maintained by the United States Patent and Trademark Office covering US granted utility patents from 2015 to 2025.

How to use this portfolio

Qiagen's 6 grants land it in the top 37% by Innovation Score, but volume alone doesn't tell you where the strength sits.

Read that count against the largest US assignees before treating it as dominance - Qiagen ranks #42,488 of 50,000. Top 50 holders
Most of this portfolio concentrates in G01N - see who else leads that technology area. G01N leaders
Check what the four-part Innovation Score actually rewards before comparing it to another company. How the score works

Patent counts and the Innovation Score measure patenting activity, not commercial success or the legal strength of any patent. Many patents are filed defensively. Verify the status of an individual patent against official USPTO records.

Data sourced from USPTO PatentsView - official U.S. government patent data. See our methodology for computation details. Retrieved and formatted by PlainPatent Editorial

Disclaimer: This information is provided for informational purposes only and does not constitute professional advice. Data is sourced from the USPTO PatentsView database. Consult a qualified professional before making decisions based on this data.

Read our methodology - how this data is sourced, computed, and verified.

Data sources used on this page

USPTO PatentsView - the disambiguated bulk patent-grant, assignee, and CPC data this page's figures are derived from. patentsview.org
Cooperative Patent Classification (CPC) - the joint USPTO/EPO classification scheme used to group patents by technology area. cooperativepatentclassification.org
USPTO Patent Public Search - the official interface to verify the status of any individual patent. ppubs.uspto.gov

Compiled byPlainPatent Editorial, US Patent Intelligence Editorial Team · May 15, 2026

Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.